Phase III Trials 'Hit a Home Run' in Advanced Endometrial Cancer
(MedPage Today) -- TAMPA, Fla. -- Immunotherapy combined with standard chemotherapy significantly improved progression-free survival (PFS) in patients with advanced or recurrent endometrial cancer, according to results from two randomized phase...
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news
More News: Cancer | Cancer & Oncology | Chemotherapy | Endometrial Cancer | Hematology | Immunotherapy